Bleakley Financial Group, LLC

Position in ZTS — Zoetis Inc.

CIK 1936953 PARSIPPANY, NJ

Position in ZTS

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$2,216,201

+$203,853 QoQ

Shares Held

18,748

+51.8% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bleakley Financial Group, LLC holds $14,751,437 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (15.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	431,602	$7,993,269
2	ZTS	Zoetis Inc. This page	18,748	$2,216,201
3	LNTH	Lantheus Holdings, Inc.	13,951	$1,058,183
4	LQDA	Liquidia Corp	22,855	$862,547
5	PBH	Prestige Consumer Healthcare Inc.	12,245	$725,761
6	AQST	Aquestive Therapeutics, Inc.	135,767	$563,433
7	HROW	Harrow, Inc.	13,183	$464,832
8	ALKS	Alkermes plc.	10,064	$355,863

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,216,201	18,748	+51.8%	Shares	Sole	2026-05-04
2024-12-31	$2,012,348	12,351	+15.0%	Shares	Sole	2025-01-27
2024-09-30	$2,098,185	10,739	-71.9%	Shares	Sole	2024-10-16
2024-06-30	$6,634,833	38,272	-35.0%	Shares	Sole	2024-08-12
2024-03-31	$9,959,869	58,861	+7.3%	Shares	Sole	2024-05-08
2023-12-31	$10,828,310	54,863	+7.9%	Shares	Sole	2024-01-25
2023-09-30	$8,844,969	50,839	+3.0%	Shares	Sole	2023-11-14
2023-06-30	$8,495,980	49,335	+13.4%	Shares	Sole	2023-08-14
2023-03-31	$7,240,639	43,503	+62.7%	Shares	Sole	2023-05-12
2022-12-31	$3,917,281	26,730	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.